| Alicia Gerke, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 356-1616 | |
| (319) 353-6406 |
| Full Name | Alicia Gerke |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053520759 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.
AdMeTech Foundation, a nonprofit organization, announced today that the U.S. Congress has approved $1.6 million for funding of its groundbreaking research program aimed at developing novel imaging technologies for early prostate cancer detection, which in turn is critical for saving lives and designing customized patient care, including the most effective and the least invasive approach.
Many human proteins are not as good as they might be because the gene sequences that code for them have a double role which slows down the rate at which they evolve, according to new research published in PLoS Biology.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.
› Verified 8 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.
AdMeTech Foundation, a nonprofit organization, announced today that the U.S. Congress has approved $1.6 million for funding of its groundbreaking research program aimed at developing novel imaging technologies for early prostate cancer detection, which in turn is critical for saving lives and designing customized patient care, including the most effective and the least invasive approach.
Many human proteins are not as good as they might be because the gene sequences that code for them have a double role which slows down the rate at which they evolve, according to new research published in PLoS Biology.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Gerke, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-1616 | Alicia Gerke, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-1616 |
News Archive
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.
AdMeTech Foundation, a nonprofit organization, announced today that the U.S. Congress has approved $1.6 million for funding of its groundbreaking research program aimed at developing novel imaging technologies for early prostate cancer detection, which in turn is critical for saving lives and designing customized patient care, including the most effective and the least invasive approach.
Many human proteins are not as good as they might be because the gene sequences that code for them have a double role which slows down the rate at which they evolve, according to new research published in PLoS Biology.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.
› Verified 8 days ago
Rami G. El Abiad, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4901 Fax: 319-384-8559 | |
Grerk Sutamtewagul, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Internal Medicine, Iowa City, IA 52242 Phone: 319-356-1616 Fax: 319-353-8383 | |
Dr. Kaleb Tanner Veit, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 Hawkins Drive, Iowa City, IA 52242 Phone: 319-353-6239 Fax: 319-353-6406 | |
Dr. Elizabeth R Bowen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Department Of Internal Medicine, Iowa City, IA 52242 Phone: 319-353-7842 Fax: 319-353-7850 | |
Balarama Krishna Surapaneni, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4019 Fax: 319-353-8073 | |
Soorih Shaikh, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2148 Fax: 319-353-8383 | |
Dr. Richard Ellis Larew, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2460 Towncrest Dr, Iowa City, IA 52240 Phone: 319-338-7862 |